[PDF][PDF] 达格列净治疗糖尿病合并慢性心力衰竭的临床研究
杨顺昱， 江戈， 杨兰， 易军， 麦炜颐 - 新医学, 2021 - xinyixue.cn
… [Abstract] Objective To evaluate the clinical efficacy of dapagliflozin in the treatment of
diabetes mellitus complicated with chronic heart failure (CHF),and investigate the effect upon …
diabetes mellitus complicated with chronic heart failure (CHF),and investigate the effect upon …
沙库巴曲缬沙坦对心力衰竭患者肾功能及肾脏安全性影响的Meta 分析
马洲， 倪利华， 胡纯， 常丰沛， 吴小燕 - 临床肾脏病杂志, 2022 - lcszb.com
… ,ACEI)/血管紧张素受体阻断剂(angiotensin receptor blocker,ARB)相比,沙库巴曲缬沙坦显著…
of sacubitril valsartan on renal function and renal safety in patients with heart failure(HF) so …
of sacubitril valsartan on renal function and renal safety in patients with heart failure(HF) so …
[HTML][HTML] Effectiveness of Zhuling decoction (猪苓汤) on diuretic resistance in patients with heart failure: a randomized, controlled trial
Y CHEN, L FAN, T ZHANG, X LIU - Journal of Traditional Chinese …, 2022 - m.fx361.com
… drugs to improve heart function (such as sacubitril/valsartan,… inhibitors/angiotensin receptor
antagonists,beta-blockers,and … There are few doubleblind,controlled and randomized trials …
antagonists,beta-blockers,and … There are few doubleblind,controlled and randomized trials …
[PDF][PDF] 肾素-血管紧张素系统抑制剂在腹膜透析中应用的临床研究进展
卓敏， 许戎， 董捷 - 中华肾脏病杂志, 2013 - cjn.org.cn
… ACE⁃inhibitor therapy in patients with heart failure or left ⁃ … in hypertension study (LIFE): a
randomised trial against atenolol. … inhibitors and angiotensin receptor blockers in peritoneal …
randomised trial against atenolol. … inhibitors and angiotensin receptor blockers in peritoneal …
[HTML][HTML] Effectiveness of Zhuling decoction (猪苓汤) on diuretic resistance in patients with heart failure: a randomized, controlled trial
C Yunhu, F Lihua, T ZHANG… - Journal of Traditional …, 2022 - ncbi.nlm.nih.gov
… drugs to improve heart function (such as sacubitril/valsartan, … inhibitors/angiotensin receptor
antagonists, beta-blockers, … There are few double-blind, controlled and randomized trials …
antagonists, beta-blockers, … There are few double-blind, controlled and randomized trials …
沙库巴曲缬沙坦治疗心力衰竭的研究进展
张䶮， 范延红， 孙冬冬 - 心脏杂志, 2020 - heartj.cn
… in the field of chronic heart failure treatment worldwide in recent years, sacubitril-valsartan
is a combination drug that contains the neprilysin inhibitor sacubitril and angiotensin receptor …
is a combination drug that contains the neprilysin inhibitor sacubitril and angiotensin receptor …
[HTML][HTML] 沙库巴曲缬沙坦对于心衰的应用研究进展
彭鹏， 朱军慧 - Advances in Clinical Medicine, 2023 - hanspub.org
… needs of patients with heart failure to … valsartan is an enkepha-lin/angiotensin receptor
inhibitor (ARNI). A large number of clinical trial results have shown that sacubitril-valsartan …
inhibitor (ARNI). A large number of clinical trial results have shown that sacubitril-valsartan …
血管紧张素受体-脑啡肽酶抑制剂治疗射血分数保留型心力衰竭的研究进展
巫雨恬， 孙育民， 王骏 - 心脏杂志, 2022 - heartj.cn
… an angiotensin receptor–neprilysin inhibition, has a definite curative effect on heart
failure patients with reduced … ;angiotensin receptor–neprilysin inhibition;sacubitril/valsartan;treatment …
failure patients with reduced … ;angiotensin receptor–neprilysin inhibition;sacubitril/valsartan;treatment …
Tongxinluo capsule (通心络胶囊) for cardiac syndrome X: a systematic review and meta-analysis
H Mao, M Liu, H Qu, L Wang, D Shi - Chinese journal of integrative …, 2018 - Springer
… (1) Angina pectoris of ischemic heart disease is usually characterized by symptomatic …
blockers, CCBs, angiotensinconverting enzyme inhibitors, angiotensin receptor blockers etc. The …
blockers, CCBs, angiotensinconverting enzyme inhibitors, angiotensin receptor blockers etc. The …
血管紧张素受体脑啡肽酶抑制剂: 肥胖性高血压治疗“不二之选”
王丽霞， 韩拓， 王怡雯， 张春艳， 李永勤， 王聪霞 - 心脏杂志, 2023 - heartj.cn
… 肽酶抑制剂(angiotensin receptor-neprilysin inhibitor, ARNI) 是一… 血分 数减低心力衰竭(heart
failure with reduced ejection fraction, … of ARNI to be marketed in the world, sacubitril/valsartan …
failure with reduced ejection fraction, … of ARNI to be marketed in the world, sacubitril/valsartan …